Gsa Capital Partners LLP Lifevantage Corp Transaction History

Gsa Capital Partners LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$6.9 - $9.59 $156,015 - $216,839	-22,611 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$8.58 - $10.21 $194,002 - $230,858	22,611 New	22,611 $211,000
Q3 2020 Nov 06, 2020	SELL	$12.07 - $15.31 $140,555 - $178,284	-11,645 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$10.25 - $16.54 $523,969 - $845,508	-51,119 Reduced 81.45%	11,645 $157,000
Q1 2020 May 12, 2020	BUY	$7.91 - $16.96 $496,463 - $1.06 Million	62,764 New	62,764 $646,000
Q3 2019 Nov 12, 2019	SELL	$10.8 - $14.6 $291,621 - $394,229	-27,002 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$10.68 - $14.55 $77,729 - $105,894	-7,278 Reduced 21.23%	27,002 $350,000
Q1 2019 May 15, 2019	SELL	$12.54 - $16.12 $310,992 - $399,776	-24,800 Reduced 41.98%	34,280 $490,000
Q4 2018 Feb 12, 2019	BUY	$10.06 - $14.87 $230,374 - $340,523	22,900 Added 63.29%	59,080 $779,000
Q3 2018 Nov 13, 2018	BUY	$6.33 - $13.02 $229,019 - $471,063	36,180 New	36,180 $398,000

3.85M

43.5K

2.3K

Ticker LFVN
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 12,560,000
Market Cap $275M
Description
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.